Examining Latent Tuberculosis Infection in Health-care Workers and Students

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the prevalence of Latent Tuberculosis Infection (LTBI) among health care workers and students at Fondazione Policlinico Universitario A. Gemelli IRCCS in Rome. It employs a cross-sectional survey to assess the number of individuals infected with Mycobacterium tuberculosis who show no clinical symptoms of the disease. Additionally, the study aims to identify potential risk factors associated with LTBI in this specific cohort. Participants will complete a questionnaire on dedicated tablets to gather relevant data.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* all health-care workers of Fondazione Policlinico Universitario A. Gemelli IRCCS in Rome,
* all students of all three-year and single-cycle degree courses, master's degree courses, graduate schools of the faculty of Medicine and Surgery of the Catholic University of Sacred Heart in Rome, trained at the Fondazione Policlinico Universitario A. Gemelli IRCCS,
* written informed consent.

Exclusion Criteria:

* denied informed consent.

Where it's running

• UOSD Allergologia e Immunologia Clinica, Fondazione Policlinico Universitario A. Gemelli IRCCS
  Roma, Italy Recruiting

Study contacts

• Principal investigator: Angela Rizzi, MD, PhD — Catholic University of Sacred Heart
• Study coordinator: Angela Rizzi, MD, PhD
• Email: angela.rizzi@policlinicogemelli.it
• Phone: +390630154965

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Window-period preventive treatment to prevent TB infection in children and adolescents.

  This trial will try weekly isoniazid plus rifapentine for 12 weeks to see if it prevents TB infection in household contacts aged 5 to 17 years who are IGRA-negative after recent exposure.

  Recruiting at 5 sites Pontificia Universidad Catolica de Chile · Calama, Antofagasta and 12 other locations · NCT07086820

• Screening for tuberculosis in high-risk groups in Barcelona

  This study is trying to find and test people in high-risk groups in Barcelona for tuberculosis to help catch and treat the disease early.

  Recruiting Fundació Institut Germans Trias i Pujol · Badalona · NCT06706596

• Understanding lung immune responses and microbiome after tuberculosis exposure

  This study looks at how the lungs' immune system and bacteria change in people who have recently been around someone with tuberculosis to help improve future vaccines.

  Recruiting at 3 sites University of Oxford · Oxford, Oxfordshire and 2 other locations · NCT06526689

• Doxycycline added to standard treatment for central nervous system tuberculosis

  This trial tests whether adding doxycycline to standard anti‑TB therapy and corticosteroids helps adults with central nervous system tuberculosis live longer or have less severe neurological disability.

  Recruiting at 5 sites Phase 2 National University Hospital, Singapore · Medan, Medan and 5 other locations · NCT06446245

• Shortened treatment for tuberculosis in children

  This study is testing if a shorter 2-month treatment for tuberculosis works just as well and is safe for children under 10 as the usual 4- to 6-month treatment.

  Recruiting at 9 sites Phase 3 Johns Hopkins University · Chennai and 8 other locations · NCT06253715

• Understanding TB Infection Risks in Health Workers

  This study is trying to understand how health workers in Cape Town respond to tuberculosis infections over a year to find better ways to protect them from getting sick.

  Recruiting Beth Israel Deaconess Medical Center · Cape Town · NCT06221488

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.